Year: 2022

Cellusion_logo_Medium

Cellusion and Minaris Regenerative Medicine, a member of Showa Denko Materials, Enter into Business Alliance for the Manufacturing of CLS001 for a Corneal Endothelial Cell Regenerative Therapy

TOKYO--(BUSINESS WIRE)--Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusion”), a Japanese regenerative medicine startup aiming to solve the global corneal...

news_6

Discover the Importance of Lifelong Learning and In-Demand Skills for Future Workplaces: National University of Singapore Postgraduate by Coursework Fair (NUS PGCF) 2022